Publicaciones en colaboración con investigadores/as de Instituto de Investigación Sanitaria Gregorio Marañón (45)

2023

  1. A second update on mapping the human genetic architecture of COVID-19

    Nature

  2. Analysis of common genetic variation across targets of microRNAs dysregulated both in ASD and epilepsy reveals negative correlation

    Frontiers in Genetics, Vol. 14

  3. Autism care pathway in Europe

    European Psychiatry, Vol. 66, Núm. 1

  4. Autism with co-occurring epilepsy care pathway in Europe

    European Psychiatry, Vol. 66, Núm. 1

  5. Country-level gender inequality is associated with structural differences in the brains of women and men

    Proceedings of the National Academy of Sciences of the United States of America, Vol. 120, Núm. 20

  6. Progressive loss of cortical gray matter in first episode psychosis patients with auditory hallucinations

    Schizophrenia Research

  7. Recent natural selection conferred protection against schizophrenia by non-antagonistic pleiotropy

    Scientific Reports, Vol. 13, Núm. 1

  8. Role of cortical excitatory/inhibitory imbalance in autism spectrum disorders from a symptom severity trajectories framework: a study protocol

    BMC psychiatry, Vol. 23, Núm. 1, pp. 213

  9. Structural covariance predictors of clinical improvement at 2-year follow-up in first-episode psychosis

    Progress in Neuro-Psychopharmacology and Biological Psychiatry, Vol. 120

  10. Systematic Review and Meta-analysis: Efficacy of Pharmacological Interventions for Irritability and Emotional Dysregulation in Autism Spectrum Disorder and Predictors of Response

    Journal of the American Academy of Child and Adolescent Psychiatry, Vol. 62, Núm. 2, pp. 151-168

2022

  1. An exploratory analysis of parental autism traits, age at conception and polygenic background in Autism Spectrum Disorders

    Revista de Psiquiatria y Salud Mental

  2. Clinical and treatment predictors of relapse during a three-year follow-up of a cohort of first episodes of schizophrenia

    Schizophrenia Research, Vol. 243, pp. 32-42

  3. NRN1 Gene as a Potential Marker of Early-Onset Schizophrenia: Evidence from Genetic and Neuroimaging Approaches

    International Journal of Molecular Sciences, Vol. 23, Núm. 13

  4. Novel genes and sex differences in COVID-19 severity

    Human molecular genetics, Vol. 31, Núm. 22, pp. 3789-3806

  5. Pharmacological and dietary-supplement treatments for autism spectrum disorder: a systematic review and network meta-analysis

    Molecular Autism, Vol. 13, Núm. 1

  6. Polygenic contribution to the relationship of loneliness and social isolation with schizophrenia

    Nature Communications, Vol. 13, Núm. 1

  7. Prefrontal abnormalities, executive dysfunction and symptoms severity are modulated by COMT Val158Met polymorphism in first episode psychosis: Prefrontal abnormalities, executive dysfunction and symptoms severity

    Revista de Psiquiatria y Salud Mental, Vol. 15, Núm. 2, pp. 74-87

  8. Virtual Ontogeny of Cortical Growth Preceding Mental Illness

    Biological Psychiatry, Vol. 92, Núm. 4, pp. 299-313

2021

  1. A Phase II Randomized, Double-Blind, Placebo-Controlled Study of the Efficacy, Safety, and Tolerability of Arbaclofen Administered for the Treatment of Social Function in Children and Adolescents With Autism Spectrum Disorders: Study Protocol for AIMS-2-TRIALS-CT1

    Frontiers in Psychiatry, Vol. 12

  2. A white paper on a neurodevelopmental framework for drug discovery in autism and other neurodevelopmental disorders

    European Neuropsychopharmacology, Vol. 48, pp. 49-88